No Data
Sunshine Group (02522) has appointed Chen Chaoyang as the director and CEO.
Yimai Sunshine (02522) announced that after the special general meeting of shareholders, the board of directors has convened the first meeting of the second session of the board of directors.
Express News | Jiangxi Rimag- Appointment of Chen Zhaoyang as Chairman of Second Session of Board
Jiangxi Rimag Group's Subsidiary to Acquire 18% Equity Interest in Financial Solutions Services Company
Yimai Yangguang (02522.HK) plans to acquire 18% equity of Shanghai Ronggongshe Fanghou Technology for 17.28 million yuan.
On November 1, Gleonhui announced that on November 1, 2024, OneSunshine (02522.HK) Health Management (a wholly-owned subsidiary of the company), the seller Qingcheng Fanghou No. 1 Investment Partnership Enterprise (Limited Partnership), the target company Shanghai Ronggongshe Fanghou Technology Co., Ltd., Fanghou Investment, and Fanghou No. 2 entered into an equity transfer agreement for the sale and purchase of 18.0% equity of the target company. The consideration for the acquisition is RMB 17.28 million, which will be paid in cash in one lump sum by OneSunshine Health Management to the seller upon completion. The consideration payable by OneSunshine Health Management for the acquisition will be financed by the group's internal funds.
Express News | Jiangxi Rimag - Unit to Acquire 18.0% Stake in Shanghai Ronggongshe Fanghou Technology
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
No Data
No Data
